Evidence map›Paper›PMID 41824329›Full record

ArticleThe Journal of general virology2026

The anti-viral protein Shiftless blocks p-body formation during KSHV infection.

David Hatfield, William Rodriguez, Timothy Mehrmann, Mandy Muller

Abstract read
In one paragraph

Article in The Journal of general virology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

David HatfieldDepartment of Microbiology, University of Massachusetts, Amherst, USA.
William RodriguezDepartment of Microbiology, University of Massachusetts, Amherst, USA.
Timothy MehrmannDepartment of Microbiology, University of Massachusetts, Amherst, USA.
Mandy MullerInstitute of Microbiology, University Hospital of Lausanne, University of Lausanne, Lausanne, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Processing bodies (P-bodies/PBs) are non-membranous foci involved in coordinating RNA fate by regulating translation and mRNA decay. In this study, we characterize the anti-viral factor Shiftless (SHFL) as a potent disruptor of PB dynamics. We show SHFL expression restricts PB accumulation even in the context of oxidative stress, suggesting that SHFL expression impedes PB formation. Mutational approaches revealed that SHFL RNA-binding activity is not required to restrict PB formation. However, we have identified a new region of SHFL, a bridge between two distant SHFL domains, as necessary for SHFL-mediated PB disruption. Furthermore, we show that SHFL's ability to disrupt PB formation also impacts its anti-viral activity during infection by the gammaherpesvirus Kaposi's sarcoma-associated herpesvirus (KSHV). While WT SHFL efficiently restricts KSHV lytic reactivation, SHFL mutants defective in PB disruption no longer restrict KSHV reactivation. SHFL-mediated PB disruption also leads to increased expression of several anti-viral cytokines, further emphasizing the connection among SHFL, PB dynamics and the SHFL-dependent anti-viral state. Taken together, our observations suggest a role of SHFL in inhibiting PB formation to restrict KSHV lytic replication, reinforcing the importance of crosstalk between RNA fate and the innate immune response to viral infection.

Indexed as

Herpesviridae InfectionsHerpesvirus 8, HumanRNA-Binding ProteinsViral ProteinsCell LineHost-Pathogen InteractionsHumansRNA StabilityRNA, ViralVirus ActivationVirus ReplicationRNA-Binding ProteinsRNA, ViralViral ProteinsherpesvirusKaposi’s sarcoma-associated herpesvirus (KSHV)processing body (P-body)RNA decayShiftless (SHFL)

Identifiers

PMID41824329
PMCPMC12987661

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.